Pearl River Capital, LLC Ab Cellera Biologics Inc. Transaction History

Pearl River Capital, LLC

  • $0
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$7.31 - $11.18 $95,658 - $146,301
13,086 Added 67.55%
32,458 $244,000
Q4 2022

Feb 13, 2023
SELL
$9.48 - $14.52 $407,658 - $624,389
-43,002 Reduced 68.94%
19,372 $196,000
Q3 2022

Nov 14, 2022
BUY
$9.2 - $13.68 $334,107 - $496,802
36,316 Added 139.37%
62,374 $617,000
Q2 2022

Aug 12, 2022
BUY
$5.72 - $10.65 $149,051 - $277,517
26,058 New
26,058 $278,000

Others Institutions Holding ABCL

# of Institutions
153
Shares Held
109M
Call Options Held
153K
Put Options Held
194K
View Full List

About AbCellera Biologics Inc.

ABCL Quotes by TradingView
  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $787M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Pearl River Capital, LLC Portfolio

Follow Pearl River Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pearl River Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email